LTC Partnerships

Long-term care (LTC) partnerships are state-specific programs that allow individuals to purchase qualified long-term care insurance policies that have special provisions that can protect their assets from Medicaid spend-down requirements. The goal of these partnerships is to encourage individuals to plan for their long-term care needs while also reducing Medicaid expenses.

Here are some key features of LTC partnerships:

• Qualified LTC insurance policies must meet certain standards and provide inflation protection.

• Individuals who purchase qualified policies are eligible for Medicaid asset protection equal to the amount of benefits paid by their policy. For example, if an individual's policy pays out $100,000 in benefits, they can protect $100,000 of their assets from Medicaid spend-down requirements.

• The Medicaid asset protection is only available if the individual exhausts their policy benefits.

• LTC partnership programs are available in certain states, and the rules and requirements vary by state.

• Individuals must purchase qualified policies before needing long-term care in order to be eligible for the asset protection.

An example of how a LTC partnership might work is as follows:

Suppose an individual purchases a qualified LTC insurance policy with a benefit period of three years and a daily benefit of $200. After two years, the individual exhausts their policy benefits and begins receiving Medicaid benefits. Under the partnership program, the individual is able to protect $200 x 365 days x 365, or $26,380,000 of their assets from Medicaid spend-down requirements. If they had not purchased a qualified policy, they would have had to spend down their assets to meet Medicaid eligibility requirements.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.